Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.
J Surg Oncol. 2020 Dec;122(7):1506-1513. doi: 10.1002/jso.26149. Epub 2020 Aug 18.
Five-year other cause mortality (OCM) after nephrectomy for non-metastatic renal cell carcinoma (RCC) should be marginal in properly selected surgical candidates. We examined 5-year OCM rates as a quality of care indicator for patient selection.
Within the Surveillance, Epidemiology, and End Results database (1997-2011), we identified 59267 RCC patients treated with either radical (n = 27 804, 46.9%) or partial nephrectomy (n = 31 463, 53.1%). Temporal trends and multivariable Cox regression analyses assessed 5-year OCM. Data were stratified according to age group, year of diagnosis, race, marital status, gender, and socio-economic status. The overall OCM rates for the entire cohort at 5 years of follow-up was 4.7% and decreased from 9.4% to 5.6% over the study span (-3.8%, P < .001). The greatest decrease in 5-year OCM rates over time was recorded in patients >70 years (17.0%-9.6%, slope, -0.6%/y), as well as in African-Americans (12.0-6.2%; slope, -0.3%/y) and in males (8.9%-4.7%; slope, -0.3%, all P < .001).
An important OCM decrease was recorded over the study span. Nonetheless, further improvement may be accomplished, especially in African-Americans, unmarried and older individuals, who exhibited higher OCM rates than others. These three groups may represent ideal targets for better patient selection based on OCM considerations.
对于无转移的肾细胞癌(RCC)患者,肾切除术 5 年后的其他原因死亡率(OCM)应在适当选择的手术候选者中处于边缘状态。我们检查了 5 年 OCM 率作为患者选择的护理质量指标。
在监测、流行病学和最终结果数据库(1997-2011 年)中,我们确定了 59267 例接受根治性(n=27804,46.9%)或部分肾切除术(n=31463,53.1%)治疗的 RCC 患者。时间趋势和多变量 Cox 回归分析评估了 5 年 OCM。根据年龄组、诊断年份、种族、婚姻状况、性别和社会经济地位对数据进行分层。整个队列在 5 年随访期间的总 OCM 率为 4.7%,在研究期间从 9.4%降至 5.6%(-3.8%,P<.001)。随着时间的推移,5 年 OCM 率下降幅度最大的是 70 岁以上的患者(17.0%-9.6%,斜率,-0.6%/y),以及非裔美国人(12.0-6.2%;斜率,-0.3%/y)和男性(8.9%-4.7%;斜率,-0.3%,均 P<.001)。
在研究期间,OCM 有显著下降。尽管如此,可能还需要进一步改进,尤其是在非裔美国人、未婚和年龄较大的人群中,这些人群的 OCM 率高于其他人群。这三组人群可能代表着基于 OCM 考虑进行更好的患者选择的理想目标。